In the TRIUMPH-4 Phase 3 results released last December, paresthesia was confirmed in 8.8% of the 9mg group and 20.9% of the 12mg group
Long-acting, subcutaneously administered, PYY RA are undergoing early phase clinical trials as obesity treatments either alone or in combination with GLP-1 RA (Table 1, NCT02568306 and NCT03574584)
Its designed to stimulate the pituitary gland to increase the production of growth hormone (GH) , which in turn raises levels of IGF-1 a key hormone involved in metabolism, fat burning, and muscle maintenance
Does Aetna Cover Ozempic for Weight Loss
[PMID: 8815189] PubMed record related to this compound for laboratory literature review
If you experience dizziness, severe nausea, abdominal pain, or signs of low blood sugar, discontinue berberine and contact your provider immediately